JBS logged a lower third-quarter profit, citing a difficult operating environment across several business units. The stock fell 7.3% to $12.16 after-hours.

Hims & Hers Health narrowed its sales outlook and reported an unexpected loss in the third quarter, driven by higher costs. The stock was off 2.8% at $22.30.

Skydance detailed plans to cut at least $6 billion in annual costs after its deal to combine Paramount and Warner Bros. Discovery, as the company's third-quarter revenue came in below analyst expectations. Shares were down 2.1% at $8.52 after Monday's closing bell.

Rocket Lab posted a wider-than-expected loss in the third quarter. Shares declined 6.6% to $55.00.